跳至主要内容
临床试验/NCT01529567
NCT01529567已完成不适用

Cognitive Behavioral Therapy With Our Without Exposure Therapy for Irritable Bowel Syndrome

Karolinska Institutet0 个研究点目标入组 311 人开始时间: 2011年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
311
主要终点
Gastrointestinal symptom rating scale

研究概览

简要总结

Patients with a diagnosis of irritable bowel syndrome (IBS) are recruited by self-referral. They are randomized to two 10 weeks of internet-delivered cognitive behavioral programs. Both programs include mindfulness training, education about how excessive avoidant and control behaviors maintain IBS symptoms, and changing of these behaviors to live a richer life. One of the programs also includes instructions on how to perform systematic exposure. The hypothesis of the study is while both groups will show improvement in terms of IBS symptom severity and quality of life, the addition of systematic exposure will lead to more improvement in symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Fluency in Swedish
  • •IBS-diagnosis established by physician
  • •Fulfillment of Rome III criteria for IBS

排除标准

  • •Diarrhea predominance with no colonoscopy performed
  • •Blood in stool without benign medical explanation
  • •Rapid weight loss without benign medical explanation
  • •Ongoing alcohol or drug abuse
  • •Suicidal ideation

研究组 & 干预措施

CBT without exposure

Active Comparator

干预措施: Cognitive Behavioral Therapy without exposure (Behavioral)

CBT with exposure

Experimental

干预措施: Cognitive Behavioral Therapy with exposure (Behavioral)

结局指标

主要结局

Gastrointestinal symptom rating scale

时间窗: 36 weeks after randomization (i.e. 6 months after conclusion of treatment)

Gastrointestinal symptom rating scale

时间窗: 1 week before randomization

Gastrointestinal symptom rating scale

时间窗: 10 weeks after randomization (i.e. after conclusion of treatment)

次要结局

  • Irritable Bowel Syndrome Quality of Life Instrument (IBS-QOL)(36 weeks after randomization (i.e. 6 months after conclusion of treatment))
  • Visceral Sensitivity Index (VSI)(36 weeks after randomization (i.e. 6 months after conclusion of treatment))
  • Irritable Bowel Syndrome Quality of Life Instrument (IBS-QOL)(1 week before randomization)
  • Irritable Bowel Syndrome Quality of Life Instrument (IBS-QOL)(10 weeks after randomization (i.e. after conclusion of treatment))
  • Visceral Sensitivity Index (VSI)(1 week before randomization)
  • Visceral Sensitivity Index (VSI)(10 weeks after randomization (i.e. after conclusion of treatment))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brjann Ljotsson

Principal Investigator

Karolinska Institutet

相似试验